Concepts (93)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sarcoma, Ewing | 2 | 2023 | 112 | 0.930 |
Why?
|
| Bone Neoplasms | 3 | 2023 | 424 | 0.880 |
Why?
|
| Neuroectodermal Tumors, Primitive, Peripheral | 1 | 2023 | 17 | 0.860 |
Why?
|
| Acrylamides | 1 | 2020 | 18 | 0.740 |
Why?
|
| Aminopyridines | 1 | 2020 | 53 | 0.710 |
Why?
|
| p21-Activated Kinases | 1 | 2020 | 59 | 0.710 |
Why?
|
| ras Proteins | 1 | 2020 | 136 | 0.680 |
Why?
|
| Pyrroles | 1 | 2020 | 177 | 0.650 |
Why?
|
| Pyrazoles | 1 | 2020 | 296 | 0.610 |
Why?
|
| Rhabdomyosarcoma | 1 | 2020 | 192 | 0.600 |
Why?
|
| Apoptosis | 4 | 2020 | 1788 | 0.570 |
Why?
|
| Biomarkers, Tumor | 1 | 2020 | 1421 | 0.430 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2020 | 1889 | 0.430 |
Why?
|
| Lung Neoplasms | 1 | 2023 | 1615 | 0.420 |
Why?
|
| Glioblastoma | 2 | 2012 | 327 | 0.320 |
Why?
|
| STAT3 Transcription Factor | 2 | 2012 | 217 | 0.300 |
Why?
|
| Adenovirus E1A Proteins | 2 | 2003 | 10 | 0.270 |
Why?
|
| Tumor Cells, Cultured | 3 | 2020 | 1077 | 0.250 |
Why?
|
| HMGB1 Protein | 2 | 2003 | 33 | 0.230 |
Why?
|
| Transcription Factor TFIIA | 1 | 2003 | 2 | 0.220 |
Why?
|
| RNA-Binding Protein EWS | 1 | 2023 | 32 | 0.210 |
Why?
|
| Neoplasms | 1 | 2016 | 2749 | 0.200 |
Why?
|
| Antineoplastic Agents | 3 | 2016 | 1679 | 0.190 |
Why?
|
| Animals | 9 | 2023 | 33661 | 0.180 |
Why?
|
| Mice | 6 | 2023 | 17486 | 0.180 |
Why?
|
| Transcription, Genetic | 2 | 2003 | 1696 | 0.180 |
Why?
|
| Osteosarcoma | 1 | 2023 | 258 | 0.180 |
Why?
|
| Cell Movement | 2 | 2020 | 846 | 0.170 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2020 | 873 | 0.170 |
Why?
|
| Cell Proliferation | 2 | 2020 | 2307 | 0.160 |
Why?
|
| Radiation Tolerance | 1 | 2018 | 53 | 0.150 |
Why?
|
| Electrophoretic Mobility Shift Assay | 2 | 2008 | 48 | 0.140 |
Why?
|
| Drug Synergism | 1 | 2016 | 234 | 0.130 |
Why?
|
| MicroRNAs | 1 | 2023 | 835 | 0.130 |
Why?
|
| Necrosis | 1 | 2016 | 212 | 0.130 |
Why?
|
| Receptor, Insulin | 1 | 2015 | 67 | 0.120 |
Why?
|
| Metformin | 1 | 2015 | 137 | 0.110 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2016 | 715 | 0.100 |
Why?
|
| Cyanoacrylates | 1 | 2012 | 12 | 0.100 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2012 | 54 | 0.100 |
Why?
|
| Mice, Nude | 2 | 2012 | 697 | 0.090 |
Why?
|
| Pyridines | 1 | 2012 | 222 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2012 | 1295 | 0.080 |
Why?
|
| Neoplastic Stem Cells | 1 | 2012 | 296 | 0.080 |
Why?
|
| Cell Hypoxia | 1 | 2008 | 97 | 0.080 |
Why?
|
| Transplantation, Heterologous | 1 | 2008 | 257 | 0.080 |
Why?
|
| Neoplasm Transplantation | 1 | 2008 | 376 | 0.080 |
Why?
|
| Neovascularization, Pathologic | 1 | 2008 | 240 | 0.070 |
Why?
|
| Humans | 9 | 2023 | 121682 | 0.070 |
Why?
|
| Immunocompromised Host | 1 | 2008 | 299 | 0.070 |
Why?
|
| TATA Box | 2 | 2003 | 25 | 0.070 |
Why?
|
| TATA-Box Binding Protein | 2 | 2003 | 30 | 0.070 |
Why?
|
| Signal Transduction | 2 | 2015 | 4505 | 0.060 |
Why?
|
| Survival Analysis | 1 | 2008 | 1459 | 0.060 |
Why?
|
| Genetic Vectors | 1 | 2008 | 968 | 0.060 |
Why?
|
| Neoplasm Proteins | 1 | 2008 | 670 | 0.060 |
Why?
|
| Macrophage Colony-Stimulating Factor | 1 | 2023 | 23 | 0.060 |
Why?
|
| Binding, Competitive | 1 | 2003 | 183 | 0.050 |
Why?
|
| Macromolecular Substances | 1 | 2003 | 187 | 0.050 |
Why?
|
| Breast Neoplasms | 1 | 2015 | 2485 | 0.050 |
Why?
|
| Disease Progression | 1 | 2008 | 1968 | 0.050 |
Why?
|
| High Mobility Group Proteins | 1 | 2000 | 32 | 0.050 |
Why?
|
| Binding Sites | 1 | 2003 | 1291 | 0.040 |
Why?
|
| Child | 1 | 2020 | 24030 | 0.040 |
Why?
|
| Tumor Microenvironment | 1 | 2023 | 552 | 0.040 |
Why?
|
| Disease Models, Animal | 1 | 2008 | 4273 | 0.040 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2018 | 62 | 0.040 |
Why?
|
| Radiopharmaceuticals | 1 | 2018 | 158 | 0.040 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2018 | 137 | 0.040 |
Why?
|
| Male | 2 | 2020 | 59083 | 0.040 |
Why?
|
| Adaptation, Physiological | 1 | 2018 | 263 | 0.030 |
Why?
|
| Positron-Emission Tomography | 1 | 2018 | 284 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 2018 | 608 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2000 | 1022 | 0.030 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2018 | 429 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2018 | 492 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2018 | 3288 | 0.020 |
Why?
|
| Janus Kinase 2 | 1 | 2012 | 133 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2012 | 1102 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2012 | 816 | 0.020 |
Why?
|
| Transcription Factor TFIIB | 1 | 2000 | 10 | 0.010 |
Why?
|
| Transcription Factors, TFII | 1 | 2000 | 7 | 0.010 |
Why?
|
| Transcription Factor TFIID | 1 | 2000 | 13 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2000 | 313 | 0.010 |
Why?
|
| Glutathione Transferase | 1 | 2000 | 149 | 0.010 |
Why?
|
| Cattle | 1 | 2000 | 556 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 2000 | 483 | 0.010 |
Why?
|
| Transfection | 1 | 2000 | 1076 | 0.010 |
Why?
|
| Protein Binding | 1 | 2000 | 1734 | 0.010 |
Why?
|
| Escherichia coli | 1 | 2000 | 979 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2000 | 2038 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2000 | 2586 | 0.010 |
Why?
|
| Female | 1 | 2015 | 64437 | 0.010 |
Why?
|